Investigational Epcoritamab (DuoBody CD3xCD20) Combination Therapy Demonstrates High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
Media ReleaseCOPENHAGEN, Denmark; December 7, 2024 Results show 96 percent overall response…
Vancouver Canucks Hockey Team Announces Fortinet as Its Preferred Partner, Selects Fortinet Security Fabric Platform and Secure SD-WAN
SUNNYVALE, Calif., Dec. 02, 2024 (GLOBE NEWSWIRE) -- News Summary NHL Vancouver…